Evidence-Based Medicine Guidelines
Low molecular weight heparins for acute coronary syndromes
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Low Molecular Weight Heparins for Acute Coronary Syndromes." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/453125/all/Low_molecular_weight_heparins_for_acute_coronary_syndromes.
Low molecular weight heparins for acute coronary syndromes. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/453125/all/Low_molecular_weight_heparins_for_acute_coronary_syndromes. Accessed March 16, 2025.
Low molecular weight heparins for acute coronary syndromes. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/453125/all/Low_molecular_weight_heparins_for_acute_coronary_syndromes
Low Molecular Weight Heparins for Acute Coronary Syndromes [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/453125/all/Low_molecular_weight_heparins_for_acute_coronary_syndromes.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Low molecular weight heparins for acute coronary syndromes
ID - 453125
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/453125/all/Low_molecular_weight_heparins_for_acute_coronary_syndromes
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
